

Patient power transforming the treatment landscape
Traditionally patients were passive recipients of treatments for their ailments. With the advent of social media this landscape is slowly...


Are you ready for the ICH GCP E6 (R2) Addendum?
Since the development of the first ICH GCP Guideline, the way clinical trials are conducted has been significantly affected by the...


The right CRO partner can make all the difference
In the challenging, evolving and highly demanding landscape of clinical research, an increasing number of pharmaceutical, biotechnology comp